{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:36:05Z","timestamp":1783373765772,"version":"3.54.6"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejmech.2021.113669","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T10:51:10Z","timestamp":1624445470000},"page":"113669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A review on the structures and biological activities of anti-Helicobacter pylori agents"],"prefix":"10.1016","volume":"223","author":[{"given":"Elham","family":"Ghobadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4514-0707","authenticated-orcid":false,"given":"Zahra","family":"Ghanbarimasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-6621","authenticated-orcid":false,"given":"Saeed","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113669_bib1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"323","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113669_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/gastroent12020011","article-title":"40 Years of Helicobacter pylori: a revolution in biomedical thought","volume":"12","author":"Charitos","year":"2021","journal-title":"Gastroenterol. Insights"},{"key":"10.1016\/j.ejmech.2021.113669_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12165","article-title":"Epidemiology of Helicobacter pylori infection","volume":"19","author":"Eusebi","year":"2014","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejmech.2021.113669_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/oxfordjournals.epirev.a018040","article-title":"Helicobacter pylori: epidemiology and routes of transmission","volume":"22","author":"Brown","year":"2000","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.ejmech.2021.113669_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/1462-2920.13222","article-title":"How Helicobacter pylori senses, targets and interacts with the gastric epithelium","volume":"18","author":"Keilberg","year":"2016","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113669_bib6","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.3390\/ijms21176451","article-title":"Pathways of gastric carcinogenesis, Helicobacter pylori virulence and interactions with antioxidant systems, vitamin C and phytochemicals","volume":"21","author":"Toh","year":"2020","journal-title":"Int. J. Mol."},{"key":"10.1016\/j.ejmech.2021.113669_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0036-36342010000500012","article-title":"Receptores tipo Toll, patog\u00e9nesis y respuesta inmune a Helicobacter pylori","volume":"52","author":"S\u00e1nchez-Zauco","year":"2010","journal-title":"Salud Publica Mex."},{"key":"10.1016\/j.ejmech.2021.113669_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2014.01.001","article-title":"Synthesis and in\u00a0vitro urease inhibitory activity of N, N\u2032-disubstituted thioureas","volume":"74","author":"Khan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10120-018-0867-1","article-title":"Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination","volume":"22","author":"Maleki Kakelar","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejmech.2021.113669_bib10","first-page":"19","article-title":"A\u00a0Review of epidemiology, treatment, and management","volume":"2","author":"Thaker","year":"2016","journal-title":"J.\u00a0Clin. Gastroenterol. Treatm."},{"key":"10.1016\/j.ejmech.2021.113669_bib11","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.3748\/wjg.v24.i29.3204","article-title":"M.\u00a0Romano Helicobacter pylori and extragastric diseases: a review","volume":"24","author":"Gravina","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2021.113669_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrgastro.2013.243","article-title":"Clinical effects of Helicobacter pylori outside the stomach","volume":"11","author":"Franceschi","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2021.113669_bib13","article-title":"Treatment of Helicobacter pylori infection in 2018","volume":"23","author":"O'Morain","year":"2018","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejmech.2021.113669_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejim.2010.07.009","article-title":"Treatment of Helicobacter pylori infection: the past and the future","volume":"21","author":"Gisbert","year":"2010","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ejmech.2021.113669_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/0929867053363027","article-title":"Treatment of H. pylori infection: a review","volume":"12","author":"Candelli","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1472-8206.2005.00340.x","article-title":"Eradication of Helicobacter pylori: recent advances in treatment","volume":"19","author":"McLoughlin","year":"2005","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113669_bib17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1046\/j.1365-2036.2000.00844.x","article-title":"Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori","volume":"14","author":"Gisbert","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113669_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-5378.7.s1.6.x","article-title":"Helicobacter pylori and gastric malignancies","volume":"7","author":"Sepulveda","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejmech.2021.113669_bib19","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/JCM.42.10.4832-4834.2004","article-title":"Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt","volume":"42","author":"Sherif","year":"2004","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113669_bib20","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"Antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"M\u00e9graud","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.ejmech.2021.113669_bib21","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1007\/s00253-020-10945-w","article-title":"Helicobacter pylori treatment in the post-antibiotics era\u2014searching for new drug targets","volume":"104","author":"Roszczenko-Jasi\u0144ska","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2021.113669_bib22","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.3748\/wjg.v25.i37.5578","article-title":"Pathogenesis and clinical management of Helicobacter pylori gastric infection","volume":"25","author":"de Brito","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2021.113669_bib23","first-page":"2018","article-title":"In\u00a0vitro inhibition of Helicobacter pylori growth by redox cycling phenylaminojuglones","author":"Benites","year":"2018","journal-title":"Oxid. Med. Cell. Long."},{"key":"10.1016\/j.ejmech.2021.113669_bib24","doi-asserted-by":"crossref","first-page":"14902","DOI":"10.3390\/molecules190914902","article-title":"1,4-Naphthoquinones: from oxidative damage to cellular and inter-cellular signaling","volume":"19","author":"Klotz","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113669_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-pharmtox-010611-134517","article-title":"The chemical biology of naphthoquinones and its environmental implications","volume":"52","author":"Kumagai","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113669_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1590\/S0102-695X2011005000193","article-title":"Anti-Helicobacter pylori activity and oxidative burst inhibition by the naphthoquinone 5-methoxy-3, 4-dehydroxanthomegnin from Paepalanthus latipes","volume":"22","author":"Kitagawa","year":"2012","journal-title":"Rev. Brasil. Farmacogn."},{"key":"10.1016\/j.ejmech.2021.113669_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.20307\/nps.2016.22.3.220","article-title":"Anti-Helicobacter pylori compounds from Polygonum cuspidatum","volume":"22","author":"Khalil","year":"2016","journal-title":"Nat. Prod. Sci."},{"key":"10.1016\/j.ejmech.2021.113669_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jep.2005.11.005","article-title":"Antibacterial activity of tabebuia impetiginosa martius ex DC (taheebo) against Helicobacter pylori","volume":"105","author":"Park","year":"2006","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113669_bib29","doi-asserted-by":"crossref","first-page":"150015","DOI":"10.1098\/rsob.150015","article-title":"Targeting of Helicobacter pylori thymidylate synthase ThyX by non-mitotoxic hydroxy-naphthoquinones","volume":"5","author":"Skouloubris","year":"2015","journal-title":"Open Biol."},{"key":"10.1016\/j.ejmech.2021.113669_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41429-018-0027-1","article-title":"Anti-Helicobacter pylori activities of selected N-substituted cinnamamide derivatives evaluated on reference and clinical bacterial strains","volume":"71","author":"Klesiewicz","year":"2018","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2021.113669_bib31","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1016\/j.bmcl.2006.08.043","article-title":"In\u00a0vitro inhibitory activity of boropinic acid against Helicobacter pylori","volume":"16","author":"Epifano","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113669_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/157340641001131226125042","article-title":"Alkyl caffeates as anti-helicobacter pylori and scavenger of oxidants produced by neutrophils","volume":"10","author":"Chiquetto Paracatu","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib33","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.ejmech.2010.08.015","article-title":"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors","volume":"45","author":"Xiao","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib34","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.ejmech.2008.06.001","article-title":"Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors","volume":"44","author":"Li","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib35","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/cmdc.201000126","article-title":"Metronidazole\u2013deoxybenzoin derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8","volume":"5","author":"Luo","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113669_bib36","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1016\/j.bmcl.2010.07.094","article-title":"Identification of 3\u2032, 4\u2032, 5\u2032-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells","volume":"20","author":"Lai","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib37","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1016\/j.bmc.2007.03.045","article-title":"Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease","volume":"15","author":"Xiao","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejmech.2013.03.016","article-title":"Synthesis, structure\u2013activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors","volume":"63","author":"Xiao","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ddr.21467","article-title":"Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5\u2032-monophosphate dehydrogenase (HpIMPDH) inhibitors","volume":"80","author":"Sahu","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2021.113669_bib40","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1080\/14786419.2015.1137568","article-title":"Brasiliensic and isobrasiliensic acids: isolation from Calophyllum brasiliense Cambess. and anti-Helicobacter pylori activity","volume":"30","author":"Lemos","year":"2016","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2021.113669_bib41","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/ptr.5379","article-title":"New activities for isolated compounds from convolvulus austro-aegyptiacus as anti-ulcerogenic, anti-helicobacter pylori and their mimic synthesis using bio-guided fractionation","volume":"29","author":"Awaad","year":"2015","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2021.113669_bib42","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.bmcl.2007.03.050","article-title":"A\u00a0novel class of selective anti-Helicobacter pylori agents 2-oxo-2H-chromene-3-carboxamide derivatives","volume":"17","author":"Chimenti","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113669_bib43","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1016\/j.bmcl.2010.06.048","article-title":"Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides","volume":"20","author":"Chimenti","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejmech.2005.11.001","article-title":"Synthesis and in\u00a0vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides","volume":"41","author":"Chimenti","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib45","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/jhet.464","article-title":"Synthesis and anti-Helicobacter pylori activity of 4-(coumarin-3-yl)thiazol-2-ylhydrazone derivatives","volume":"47","author":"Chimenti","year":"2010","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib46","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1016\/j.ejmech.2010.08.045","article-title":"Structural modification of a specific antimicrobial lead against Helicobacter pylori discovered from traditional Chinese medicine and a structure\u2013activity relationship study","volume":"45","author":"Zhang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib47","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1039\/b418106a","article-title":"The first enantioselective total synthesis of the anti-Helicobacter pylori agent (+)-spirolaxine methyl ether","author":"Robinson","year":"2005","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113669_bib48","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1039\/c2md00314g","article-title":"Synthesis and anti-Helicobacter pylori activity of analogues of spirolaxine methyl ether","volume":"3","author":"Dimitrov","year":"2012","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113669_bib49","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1016\/j.bmc.2008.04.037","article-title":"Anti-Helicobacter pylori activity of derivatives of the phthalide-containing antibacterial agents spirolaxine methyl ether, CJ-12,954, CJ-13,013, CJ-13,102, CJ-13,104, CJ-13,108 and CJ-13,015","volume":"16","author":"Radcliff","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib50","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bioorg.2019.04.001","article-title":"Design, synthesis and biological evaluation of Helicobacter pylori inosine 5\u2032-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2","volume":"87","author":"Shah","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/jm9010466","article-title":"Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues","volume":"53","author":"Prazeres","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib52","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/jm0505361","article-title":"Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design","volume":"49","author":"Robinson","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/cmdc.200700307","article-title":"Competitive inhibitors of Helicobacter pylori type II dehydroquinase: synthesis, biological evaluation, and NMR studies","volume":"3","author":"S\u00e1nchez-Sixto","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113669_bib54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1039\/C0MD00097C","article-title":"Rapid assembly of potent type II dehydroquinase inhibitors via \u201cClick\u201d chemistry","volume":"1","author":"Tran","year":"2010","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113669_bib55","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.1016\/j.bmc.2010.09.045","article-title":"Inhibition of Helicobacter pylori aminoacyl-tRNA amidotransferase by chloramphenicol analogs","volume":"18","author":"Balg","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib56","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1021\/ja7100714","article-title":"Inhibition of Helicobacter pylori aminoacyl-tRNA amidotransferase by puromycin analogues","volume":"130","author":"Balg","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113669_bib57","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bmcl.2005.10.045","article-title":"Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives","volume":"16","author":"Nam","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113669_bib58","doi-asserted-by":"crossref","first-page":"111662","DOI":"10.1016\/j.ejmech.2019.111662","article-title":"14- and 15-membered lactone macrolides and their analogues and hybrids: structure, molecular mechanism of action and biological activity","volume":"182","author":"Janas","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib59","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/j.bmcl.2004.02.068","article-title":"Studies on anti-Helicobacter pylori agents. Part 3: a novel, efficacious cephem derivative, FR193879","volume":"14","author":"Yoshida","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113669_bib60","first-page":"54","article-title":"Antimicrobial activity of natural products against Helicobacter pylori: a review","volume":"13","author":"Bonif\u00e1cio","year":"2014","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.ejmech.2021.113669_bib61","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/AAC.00642-06","article-title":"In\u00a0vitro and in\u00a0vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori","volume":"51","author":"Paraschos","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113669_bib62","first-page":"103","article-title":"Chemical constituents of cymbocarpum erythraeum (dc.) boiss., and evaluation of its anti-helicobacter pylori activity","volume":"15","author":"Heidari","year":"2018","journal-title":"Turkish J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2021.113669_bib63","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1021\/np040188q","article-title":"Anti-Helicobacter pylori compounds from Santalum album","volume":"68","author":"Ochi","year":"2005","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113669_bib64","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1021\/np070260v","article-title":"Anti-Helicobacter pylori and thrombin inhibitory components from Chinese dragon's blood, Dracaena cochinchinensis","volume":"70","author":"Zhu","year":"2007","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113669_bib65","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1080\/14756366.2018.1501044","article-title":"Coptisine-induced inhibition of Helicobacter pylori: elucidation of specific mechanisms by probing urease active site and its maturation process","volume":"33","author":"Li","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib66","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1016\/j.bmc.2009.09.018","article-title":"Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors","volume":"17","author":"Mao","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib67","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/cmdc.200700097","article-title":"Metronidazole\u2013flavonoid derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8 production by AGS cells","volume":"2","author":"Li","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113669_bib68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ardp.200800022","article-title":"Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles","volume":"341","author":"Letafat","year":"2008","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2021.113669_bib69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/157340609790170506","article-title":"2-Substituted-5-nitroheterocycles: in\u00a0vitro anti-Helicobacter pylori activity and structure-activity relationship study","volume":"5","author":"Foroumadi","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib70","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.ejmech.2007.11.019","article-title":"Synthesis and in\u00a0vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1, 3, 4-thiadiazol-2-yl] thiomorpholines and related compounds","volume":"43","author":"Mirzaei","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib71","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ardp.201000013","article-title":"5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents","volume":"344","author":"Moshafi","year":"2011","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2021.113669_bib72","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00044-008-9099-y","article-title":"Synthesis and in\u00a0vitro anti-Helicobacter pylori activity of 2-[(chlorobenzyl) thio]-5-(5-nitro-2-furyl)-1, 3, 4-thiadiazoles","volume":"17","author":"Mohammadhosseini","year":"2008","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113669_bib73","first-page":"471","article-title":"Synthesis and in\u00a0vitro anti-Helicobacter pylori activity of 2-(substituted benzylthio)-5-(5-nitro-2-furyl)-1, 3, 4-thiadiazole derivatives","volume":"33","author":"Mohammadhosseini","year":"2009","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib74","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2174\/157018009789057599","article-title":"Synthesis and structure-activity relationship study of 2-substituted-5-(5-nitro-2-thienyl)-1, 3, 4-thiadiazoles as anti-Helicobacter pylori agents","volume":"6","author":"Foroumadi","year":"2009","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2021.113669_bib75","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1016\/j.bmcl.2008.04.033","article-title":"Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1, 3, 4-thiadiazoles with certain sulfur containing alkyl side chain","volume":"18","author":"Foroumadi","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib76","first-page":"281","article-title":"Anti-Helicobacter pylori activity and structure-activity relationship study of 2-Alkylthio-5-(nitroaryl)-1, 3, 4-thiadiazole derivatives","volume":"12","author":"Asadipour","year":"2013","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.ejmech.2021.113669_bib77","first-page":"2512","article-title":"2-Substituted-5-(5-nitro-furan-2-yl)-1,3,4-thiadiazoles: anti-Helicobacter pylori activity evaluation and docking study","volume":"7","author":"Alvandifar","year":"2015","journal-title":"J.\u00a0Chem. Pharmaceut. Res."},{"key":"10.1016\/j.ejmech.2021.113669_bib78","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/j.bmcl.2010.04.126","article-title":"Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide","volume":"20","author":"Ballard","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib79","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00044-012-0224-6","article-title":"5-Nitro-heteroarylidene analogs of 2-thiazolylimino-4-thiazolidinones as a novel series of antibacterial agents","volume":"22","author":"Hosseinzadeh","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113669_bib80","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1021\/acs.jmedchem.9b00355","article-title":"Design, synthesis, and efficacy testing of nitroethylene-and 7-nitrobenzoxadiazol-based flavodoxin Inhibitors against Helicobacter pylori drug-resistant clinical strains and in Helicobacter pylori-infected mice","volume":"62","author":"Salillas","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1110\/ps.28602","article-title":"Crystal structure of oxidized flavodoxin, an essential protein in Helicobacter pylori","volume":"11","author":"Freigang","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2021.113669_bib82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13543776.2019.1584612","article-title":"A\u00a0patent update on therapeutic applications of urease inhibitors (2012-2018)","volume":"29","author":"Hameed","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113669_bib83","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejmech.2013.07.047","article-title":"Synthesis, molecular docking and kinetic properties of \u03b2-hydroxy-\u03b2-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors","volume":"68","author":"Xiao","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib84","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1021\/ac60252a045","article-title":"Phenol-hypochlorite reaction for determination of ammonia","volume":"39","author":"Weatherburn","year":"1967","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib85","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1016\/j.bmc.2016.07.052","article-title":"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: synthesis, molecular docking and biological evaluation","volume":"24","author":"Shi","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib86","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejmech.2018.06.065","article-title":"Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection","volume":"156","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib87","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/j.bmc.2018.07.003","article-title":"The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections","volume":"26","author":"Ni","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib88","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinorgbio.2017.05.014","article-title":"Structural influences on the activity of bismuth (III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania","volume":"177","author":"Pathak","year":"2017","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2021.113669_bib89","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/j.bmcl.2018.08.025","article-title":"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: synthesis, biological evaluation and in silico study","volume":"28","author":"Yang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib90","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2174\/1568026619666190227212334","article-title":"Synthesis and in\u00a0vitro enzymatic studies of new 3-aryldiazenyl indoles as promising Helicobacter pylori IMPDH inhibitors","volume":"19","author":"Jangra","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib91","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejmech.2011.12.021","article-title":"Synthesis and bioevaluation of novel 3, 4, 5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells","volume":"48","author":"Chang","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib92","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1751-7915.2008.00031.x","article-title":"Glutamate racemase as a target for drug discovery","volume":"1","author":"Fisher","year":"2008","journal-title":"Microbial. Biotechnol."},{"key":"10.1016\/j.ejmech.2021.113669_bib93","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1016\/j.bmcl.2008.06.092","article-title":"Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: a novel pro-drug approach to increase exposure","volume":"18","author":"Basarab","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib94","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1016\/j.bmcl.2012.07.004","article-title":"Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty","volume":"22","author":"Basarab","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib95","doi-asserted-by":"crossref","first-page":"14275","DOI":"10.1021\/jacs.5b06110","article-title":"New antibiotic candidates against Helicobacter pylori","volume":"137","author":"Wang","year":"2015","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113669_bib96","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00044-016-1756-y","article-title":"Hydrazide-hydrazones as potential antimicrobial agents: overview of the literature since 2010","volume":"26","author":"Popio\u0142ek","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113669_bib97","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3109\/14756366.2014.1001755","article-title":"Bioactive compounds of Crocus sativus L. and their semi-synthetic derivatives as promising anti-Helicobacter pylori, anti-malarial and anti-leishmanial agents","volume":"30","author":"De Monte","year":"2015","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib98","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1021\/jm8015602","article-title":"Discovering potent inhibitors against the \u03b2-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Helicobacter pylori: structure-based design, synthesis, bioassay, and crystal structure determination","volume":"52","author":"He","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib99","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpba.2008.01.011","article-title":"Investigation of the stability of aromatic hydrazones in plasma and related biological material","volume":"47","author":"Kovarikova","year":"2008","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2021.113669_bib100","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1021\/acs.chemrev.7b00090","article-title":"Oximes and hydrazones in bioconjugation: mechanism and catalysis","volume":"117","author":"K\u00f6lmel","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113669_bib101","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1002\/anie.200802651","article-title":"Hydrolytic stability of hydrazones and oximes","volume":"47","author":"Kalia","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113669_bib102","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/acsmedchemlett.8b00334","article-title":"Famotidine, an antiulcer agent, strongly inhibits Helicobacter pylori and human carbonic anhydrases","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib103","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1080\/14756366.2019.1663416","article-title":"Anti-Helicobacter pylori activity of ethoxzolamide","volume":"34","author":"Modak","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib104","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/14756366.2011.599065","article-title":"Synthesis, inhibitory activity and molecular docking studies of two Cu (II) complexes against Helicobacter pylori urease","volume":"27","author":"Cui","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/14756360903179518","article-title":"Mechanochemical synthesis and in\u00a0vitro anti-Helicobacter pylori and uresase inhibitory activities of novel zinc (II)\u2013famotidine complex","volume":"25","author":"Amin","year":"2010","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib106","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1570180814666170309130030","article-title":"Solvent-free mechano-chemical synthesis of new omeprazole derived metal complexes: characterization, urease inhibitory kinetics and selective anti-Helicobacter pylori activity","volume":"15","author":"Amin","year":"2018","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2021.113669_bib107","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1021\/acs.jmedchem.6b00986","article-title":"1, 2-Benzisoselenazol-3 (2 H)-one derivatives as a new class of bacterial urease inhibitors","volume":"59","author":"Macegoniuk","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib108","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bmcl.2008.11.113","article-title":"Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines","volume":"19","author":"Geng","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib109","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1021\/acsmedchemlett.8b00649","article-title":"Antibacterial strategy against H. pylori: inhibition of the radical SAM Enzyme MqnE in menaquinone biosynthesis","volume":"10","author":"Joshi","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113669_bib110","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2174\/157340608785700162","article-title":"Structure-activity relationship study of a series of N-substituted piperazinyl-fluoroquinolones as anti-Helicobacter pylori agents","volume":"4","author":"Foroumadi","year":"2008","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib111","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ja.2016.36","article-title":"Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone","volume":"69","author":"Klesiewicz","year":"2016","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2021.113669_bib112","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1016\/j.bmc.2015.05.026","article-title":"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2 (5H)-ones as anti-gastric ulcer agent","volume":"23","author":"Wang","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113669_bib113","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1016\/j.bmc.2015.06.014","article-title":"Synthesis and evaluation of N-analogs of 1, 2-diarylethane as Helicobacter pylori urease inhibitors","volume":"23","author":"Xiao","year":"2015","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:33:25Z","timestamp":1759329205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421005183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":113,"alternative-id":["S0223523421005183"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113669","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on the structures and biological activities of anti-Helicobacter pylori agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113669"}}